5/27/2025Insilico Medicine Unveils AI-Designed ENPP1 Inhibitor ISM5939

5/27/2025Henlius Reports Promising Phase 1 Results for PD-L1-Targeting ADC HLX4...

5/27/2025CTTQ's Anlotinib Combination Shows Promise

5/27/2025XellSmart's iPSC-Derived Cell Therapy for Spinal Cord Injury Advances ...

5/23/2025Recent Executive Moves

5/23/2025Vigene and Merz Expand Strategic Partnership Across Greater China

5/23/2025Instil Bio and ImmuneOnco Advance PD-L1xVEGF Bispecific Antibody in NS...

5/23/2025CARsgen's Satri-cel CAR T Demonstrates Significant Efficacy in GC/GEJ

5/23/20253SBio's Bispecific Antibody SSGJ-707 Shows Promising Results in Advanc...

5/23/2025Dizal's DZD6008 Shows Promising Results in EGFR-Mutant NSCLC with Brai...

5/22/2025China Approves Hengrui's Camrelizumab-Famitinib Combo

5/22/2025Hengrui Pharma Raises $1.27B in Hong Kong Listing

5/22/2025InnoVec Secures Series A Funding to Advance AI-Driven Gene Therapy Pla...

5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD

5/22/2025China Approves Raynovent's Onradivir for Adult Influenza A Treatment

5/22/2025NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...

5/22/2025CDE Issues the Guideline on Clinical Trials for Alzheimer's Disease Dr...

5/21/2025Accropeutics Reports Phase 2 Psoriasis Success with TYK2/JAK1 Inhibito...

5/21/2025China's Drugstores Decline Amid Boom in Online Healthcare

5/21/2025China Surges Ahead in Oncology Licensing, GlobalData Reports

5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL

5/21/2025CRISPR and Sirius Forge Strategic Alliance for Next-Gen siRNA Therapy

5/21/2025CureGene Completes Series B+ Financing to Advance Cardiometabolic and ...

5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...

5/20/2025CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...

5/20/2025CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...

5/20/2025CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...

5/20/2025CDE Solicits Comments on the 94th Batch of Reference Formulations for ...

5/20/2025Innovent's XNW5004 Receives Breakthrough Therapy Designation

5/20/2025CTTQ Initiates Phase 3 Trial of HER2-Targeting Bispecific ADC TQB2102

Page:18/57 Total number of articles:1697: [First][<<] [16] [17] [18] [19] [20] [>>] [End]